A world-class solution to a world-wide need

At CIIC, we have developed a world-class solution to supply key radioisotopes, producing two products that are ideally suited to electron linear accelerator production:

  • Cu-67, a therapeutic isotope in emerging drugs used for cancer treatments,


  • Mo-99/Tc-99m required by nuclear medicine physicians for early stage diagnosis of disease (such as cancer & cardiovascular disease).

We use an advanced method of producing and distributing key medical isotopes.

Our method is the first commercially viable alternative to conventional reactor-based production.


Our product is clean and sustainable, presenting few environmental issues.


We are able to reliably supply radiopharmacies across North America due to our streamlined supply chain and dependable production facilities that can be scaled to meet regional demand.


Our process produces  pure, high quality products that ensure patients receive an effective, safe dose.

One in two people will require Tc-99m for a test that determines whether he or she has an ailment.